LabGenomics Statistics

Total Valuation

LabGenomics has a market cap or net worth of KRW 174.84 billion. The enterprise value is 134.17 billion.

Market Cap	174.84B
Enterprise Value	134.17B

Important Dates

The last earnings date was Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

LabGenomics has 74.24 million shares outstanding. The number of shares has increased by 10.68% in one year.

Current Share Class	n/a
Shares Outstanding	74.24M
Shares Change (YoY)	+10.68%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.53%
Owned by Institutions (%)	8.58%
Float	61.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.03
PB Ratio	0.81
P/TBV Ratio	1.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.64
EV / Sales	1.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.05

Financial Position

The company has a current ratio of 1.78, with a Debt / Equity ratio of 0.23.

Current Ratio	1.78
Quick Ratio	1.70
Debt / Equity	0.23
Debt / EBITDA	n/a
Debt / FCF	-3.01
Interest Coverage	-3.36

Financial Efficiency

Return on equity (ROE) is -10.66% and return on invested capital (ROIC) is -4.24%.

Return on Equity (ROE)	-10.66%
Return on Assets (ROA)	-3.79%
Return on Invested Capital (ROIC)	-4.24%
Return on Capital Employed (ROCE)	-8.43%
Revenue Per Employee	505.28M
Profits Per Employee	-139.98M
Employee Count	170
Asset Turnover	0.28
Inventory Turnover	18.54

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -29.98% in the last 52 weeks. The beta is -0.94, so LabGenomics's price volatility has been lower than the market average.

Beta (5Y)	-0.94
52-Week Price Change	-29.98%
50-Day Moving Average	2,615.30
200-Day Moving Average	2,828.75
Relative Strength Index (RSI)	24.14
Average Volume (20 Days)	577,497

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LabGenomics had revenue of KRW 85.90 billion and -23.80 billion in losses. Loss per share was -322.00.

Revenue	85.90B
Gross Profit	30.18B
Operating Income	-18.49B
Pretax Income	-25.95B
Net Income	-23.80B
EBITDA	-8.89B
EBIT	-18.49B
Loss Per Share	-322.00

Full Income Statement

Balance Sheet

The company has 90.86 billion in cash and 50.20 billion in debt, giving a net cash position of 40.66 billion or 547.71 per share.

Cash & Cash Equivalents	90.86B
Total Debt	50.20B
Net Cash	40.66B
Net Cash Per Share	547.71
Equity (Book Value)	216.31B
Book Value Per Share	2,913.71
Working Capital	59.25B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.99 billion and capital expenditures -3.67 billion, giving a free cash flow of -16.66 billion.

Operating Cash Flow	-12.99B
Capital Expenditures	-3.67B
Free Cash Flow	-16.66B
FCF Per Share	-224.45

Full Cash Flow Statement

Margins

Gross margin is 35.14%, with operating and profit margins of -21.53% and -27.70%.

Gross Margin	35.14%
Operating Margin	-21.53%
Pretax Margin	-30.21%
Profit Margin	-27.70%
EBITDA Margin	-10.35%
EBIT Margin	-21.53%
FCF Margin	n/a

Dividends & Yields

LabGenomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.68%
Shareholder Yield	-10.68%
Earnings Yield	-13.61%
FCF Yield	-9.53%

Dividend Details

Stock Splits

The last stock split was on August 7, 2023. It was a forward split with a ratio of 2.

Last Split Date	Aug 7, 2023
Split Type	Forward
Split Ratio	2

Scores

LabGenomics has an Altman Z-Score of 2.71. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.71
Piotroski F-Score	n/a